Announcements Trials
Browse Landscape

Phase

Phase 2 34Phase 3 22Phase 1 10Phase 4 6Phase NA 4Phase 2/3 4Phase 1/2 4

Status

Completed 5Unknown 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Other hematologic neoplasm 6Lymphoid 6

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Prostatic Neoplasms 3Prostate Cancer Metastatic 2Myasthenia Gravis 2Multiple Myeloma 2Waldenstrom Macroglobulinemia 1Subcutaneous panniculitis-like T-cell lymphoma 1Skin Neoplasms 1Prostatic Neoplasms, Castration-Resistant 1Pneumonia 1Pituitary Neoplasms 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1Metastatic Castration-resistant Prostate Cancer 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Lung Neoplasms 1Lung Diseases, Interstitial 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoblastic Lymphadenopathy 1Enteropathy-Associated T-Cell Lymphoma 1Dementia 1Craniopharyngioma 1Cognitive Dysfunction 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Adrenal Insufficiency 1

Interventions

Vincristine 20Cytarabine 19Methotrexate 18Dexamethasone 17Cyclophosphamide 17Mercaptopurine 16Daunorubicin 12Asparaginase 12Doxorubicin 10Prednisolone 9Granulocyte Colony-Stimulating Factor 8Idarubicin 7Etoposide 7Thioguanine 6Teniposide 6Rituximab 6Prednisone 6Vindesine 5Ifosfamide 5Stem Cell Transplantation 4fludarabine 3Mitoxantrone 3Hydrocortisone 3pegaspargase 2Ketamine 2Inotuzumab Ozogamicin 2Imatinib Mesylate 2Cladribine 2Cholecalciferol 2pegylated granulocyte colony-stimulating factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 4 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Prednisone × Clear all
NCT00853008 2020-04-07

LAL-AR/2003

PETHEMA Foundation

Phase 4 Completed
100 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00526175 2016-01-20

LAL-BR/2001: Study Treatment to Low Risk ALL

PETHEMA Foundation

Phase 4 Completed
150 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01358253 2014-05-20

Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia

Ruijin Hospital

Phase 4 Completed
100 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00526305 2010-01-05

LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive

PETHEMA Foundation

Phase 4 Completed
100 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00797810 2009-09-15

Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults

University of Bologna

Phase 4 Unknown
25 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00494897 2009-05-19

PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia

PETHEMA Foundation

Phase 4 Completed
374 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡